Jeremy Mindich
CIK 1431207 · last filed 2019-05-23
Jeremy Mindich is a corporate insider who has filed 21 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing shows the insider sold $12.7M of ITRI on May 23, 2019. Across all open-market trades the lifetime net is −$23.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $632.2M across reported positions. 109 SEC filings were submitted jointly with SCOPIA CAPITAL MANAGEMENT LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ITRI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
450 SEVENTH AVENUE, 43RD FLOOR
NEW YORK, NY 10123
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ITRI | 10%+ Owner | 4,005,794 | $87.65 | $351.11M | -$13.75M | 7 | 2019-05-23 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | 10%+ Owner | 40,551 | $0.66 | $26.8K | -$19.93M | 3 | 2019-01-22 |
| Barzel Industries Inc. (TONSW) Delisted | 10%+ Owner | 2,559,673 | — | — | $7.40M | 3 | 2009-01-06 |
| SOURCE INTERLINK COMPANIES INC (SORC) Delisted | 10%+ Owner | 5,282,276 | — | — | -$791.3K | 3 | 2008-07-02 |
| CENT | 10%+ Owner | 6,194,326 | $45.38 | $281.10M | $4.10M | 3 | 2008-05-09 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-23 | ITRI | Sell (S) | −220,344 | -$12.66M | EDGAR |
| 2019-05-01 | ITRI | Sell (S) | −167,452 | -$8.89M | EDGAR |
| 2019-03-27 | ITRI | Sell (S) | −194,736 | -$9.18M | EDGAR |
| 2019-01-22 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −557,432 | -$9.30M | EDGAR |
| 2018-11-13 | ITRI | Sell (S) | −306,776 | -$16.46M | EDGAR |
| 2018-10-09 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −615,432 | -$10.63M | EDGAR |
| 2018-10-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Other (J) | −563,616 | $0 | EDGAR |
| 2018-05-29 | ITRI | Buy (P) | +80,000 | $4.75M | EDGAR |
| 2016-03-11 | ITRI | Buy (P) | +213,068 | $8.96M | EDGAR |
| 2016-02-24 | ITRI | Buy (P) | +492,056 | $19.72M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.